Retraction
Astragaloside IV inhibits human colorectal cancer cell growth
Paper Information
Record ID:
60070
Author(s):
Journal:
Publication Date:
January 01, 2019
Retraction Date:
December 24, 2024
(<1 year years ago)
Subjects:
Institutions:
- Department of Oncology, Diamond Bay Hospital, Second Affiliated Hospital of Dalian Medical University, Dalian, 116036, China
- Department of Cardiology, Second Hospital of Dalian Medical University, Dalian, 116036, China
- Department of Urology, Second Hospital of Dalian Medical University, Dalian, 116036, China
- General Department, Second Hospital of Dalian Medical University, Dalian, 116036, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
IMR Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (32)
32
Total Citations4
Post-Retraction(12.5%)
27
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
0
After 2+ years
176
Days since retraction (latest)
Astragaloside IV: A Promising Drug to Prevent the Transition from Colitis to Colorectal Cancer
Jiayu Ran, Yanling Ai, Jiyuan Ni et al. (12 authors)
The American Journal of Chinese Medicine
Published: Jun 2025
176 days after retraction
Astragaloside IV inhibits the growth of obesity-associated triple-negative breast cancer by activating FOXA1 transcription factor to regulate GAL3ST1-GalCer signaling and remodel sphingolipid metabolism
Yaqin Yang, Jun Lü, Yimin Zhu et al. (10 authors)
Phytomedicine
Published: May 2025
156 days after retraction
Natural products target programmed cell death signaling mechanisms to treat colorectal cancer
Ya Zheng, Na Feng, C W Li et al. (4 authors)
Frontiers in Pharmacology
Open Access
Published: Apr 2025
121 days after retraction
Advancements in the Research of <i>Astragalus membranaceus</i> for the Treatment of Colorectal Cancer
Qiwen Lu, Jiaxin Jiang, Xi Wang et al. (5 authors)
The American Journal of Chinese Medicine
Published: Jan 2025
1 citation
1 citation
36 days after retraction
RETRACTED: Sun et al. Astragaloside IV inhibits human colorectal cancer cell growth. Front. Biosci. (Landmark Ed) 2019, 24(3), 597–606
Frontiers in Bioscience-Landmark Editorial Office
Frontiers in Bioscience-Landmark
Open Access
Published: Dec 2024
Same day as retraction
Pharmacological potential of natural medicine Astragali Radix in treating intestinal diseases
Xiunan Wei, Xiaohui Leng, Junwei Liang et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Oct 2024
2 citations
2 citations
69 days before retraction
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer
Yang Zhang, Qianming Kang, Luying He et al. (8 authors)
Chinese Medicine
Open Access
Published: Aug 2024
5 citations
5 citations
117 days before retraction
Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action
Feiya Sheng, Siyu Yang, Li Mi et al. (6 authors)
Molecules
Open Access
Published: Jul 2024
4 citations
4 citations
159 days before retraction
Astragaloside IV inhibits colorectal cancer metastasis by reducing extracellular vesicles release and suppressing M2-type TAMs activation
Jing Zhou, Ling Li, Yunzhou Pu et al. (12 authors)
Heliyon
Open Access
Published: May 2024
8 citations
8 citations
237 days before retraction
Astragaloside IV regulates circ_0001615 and miR‐873‐5p/LASP1 axis to suppress colorectal cancer cell progression
Pengfei Kong, Xuemei Tang, Fang Liu et al. (4 authors)
Chemical Biology & Drug Design
Published: Jan 2024
8 citations
8 citations
358 days before retraction
Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis
Liangtao Wen, Lixiang Xie, Fengying Gong et al. (5 authors)
Frontiers in Pharmacology
Open Access
Published: Dec 2023
5 citations
5 citations
379 days before retraction
The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
Tang Ziyang, Hu Xirong, An Chongming et al. (4 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Oct 2023
15 citations
15 citations
449 days before retraction
Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling
Ling Shen, Yuancheng Li, Guiying Hu et al. (7 authors)
Functional & Integrative Genomics
Published: Apr 2023
13 citations
13 citations
613 days before retraction
Mechanism exploration and prognosis study of Astragali Radix-Spreading hedyotis herb for the treatment of lung adenocarcinoma based on bioinformatics approaches and molecular dynamics simulation
Junfeng Guo, Yuting Zhao, Xuanyu Wu et al. (7 authors)
Frontiers in Chemistry
Open Access
Published: Mar 2023
10 citations
10 citations
636 days before retraction
Astragaloside IV, as a potential anticancer agent
Dongqin Xia, Wenjie Li, Ce Tang et al. (4 authors)
Frontiers in Pharmacology
Open Access
Published: Feb 2023
34 citations
34 citations
676 days before retraction
Anticancer effects and mechanisms of astragaloside‑IV (Review)
Liangxing Zhou, Mengpeng Li, Zhengbin Chai et al. (11 authors)
Oncology Reports
Open Access
Published: Nov 2022
22 citations
22 citations
777 days before retraction
Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
Tiantian Qiu, Donghua Li, Yu Liu et al. (6 authors)
Cancers
Open Access
Published: Sep 2022
12 citations
12 citations
834 days before retraction
Astragaloside-IV Inhibits Pancreatic Cancer Cell Proliferation in Vitro and in Vivo by Inducing Cell Cycle Arrest and Apoptosis
Guodong Chen, Chengming Ding, Tang Wei-ping et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Jan 2022
1086 days before retraction
Immunomodulation: An immune regulatory mechanism in carcinoma therapeutics
Rana M. Alsaffar, Shafat Ali, Summya Rashid et al. (6 authors)
International Immunopharmacology
Published: Jul 2021
11 citations
11 citations
1250 days before retraction
Potential COX2 mediated Therapeutic effect of Ciprofloxacin
Marwa Eisa, Moustafa Fathy, Maiiada Nazmy
El-Minia Medical Bulletin
Open Access
Published: Jul 2021
7 citations
7 citations
1272 days before retraction
Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1
Wei Liu, Han Chen, Dongsheng Wang
Immunopharmacology and Immunotoxicology
Published: Jun 2021
40 citations
40 citations
1289 days before retraction
Study of properties of virtual laser GB-speckles, generated on nucleotide sequences of the SARS-CoV-2 gene "N"
Sergey Zaytsev, Onega V. Ulianova, Maria A. Khizhnyakova et al. (7 authors)
Unknown Journal
Published: May 2021
1 citation
1 citation
1330 days before retraction
Molecular mechanisms of astragaloside‑IV in cancer therapy (Review)
Tianqi Chen, Peiying Yang, Yingjie Jia
International Journal of Molecular Medicine
Open Access
Published: Jan 2021
68 citations
68 citations
1447 days before retraction
Astragaloside IV Exerts Anti-tumor Effect on Murine Colorectal Cancer by Re-educating Tumor-Associated Macrophage
Feng Liu, Fang Ran, Hongqin He et al. (4 authors)
Archivum Immunologiae et Therapiae Experimentalis
Published: Oct 2020
40 citations
40 citations
1523 days before retraction
MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi et al. (7 authors)
Life Sciences
Published: Jun 2020
30 citations
30 citations
1648 days before retraction
Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis
Xiang Cui, Xiaoyan Jiang, Chunshan Wei et al. (5 authors)
Environmental Toxicology and Pharmacology
Published: Apr 2020
31 citations
31 citations
1704 days before retraction
Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion
Chenglai Xia, Zhihong He, Yantao Cai
Cellular & Molecular Biology Letters
Open Access
Published: Mar 2020
43 citations
43 citations
1729 days before retraction
Chemical diversity and biological activities of the saponins isolated from Astragalus genus: focus on Astragaloside IV
Vittoria Graziani, Monica Scognamiglio, Assunta Esposito et al. (5 authors)
Phytochemistry Reviews
Published: Jul 2019
19 citations
19 citations
1996 days before retraction
Investigation of statistical characteristics of GB-speckles, coding nucleotide sequences of the gene GPCR of Lumpy Skin Disease virus
Onega V. Ulianova, Irina Subbotina, Nadejda Filinova et al. (8 authors)
Unknown Journal
Published: Jun 2019
2031 days before retraction
Application of s-LASCA technique for processing of GB-speckles, coding sequences of nucleotide sequences of omp1 gene of Chlamydia trachomatis
Onega V. Ulianova, Yury V. Saltykov, Sergey Zaytsev et al. (8 authors)
Unknown Journal
Published: Jun 2019
2031 days before retraction
Investigation of structural and statistical characteristics of interfering GB-speckles, coding the nucleotide sequences of the gene GPCR of Lumpy Skin Disease Virus
Onega V. Ulianova, Yury V. Saltykov, Sergey Zaytsev et al. (8 authors)
Unknown Journal
Published: Jun 2019
2031 days before retraction
Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma<i>via</i>Wnt/β-catenin signaling pathway
Zhongyu Jiang, Zhen Mao
RSC Advances
Open Access
Published: Jan 2019
11 citations
11 citations
2184 days before retraction
Quick Stats
Total Citations:
32
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025